Medpace Holdings, Inc. (MEDP)
NASDAQ: MEDP · Real-Time Price · USD
653.11
+18.13 (2.86%)
At close: Nov 6, 2026, 4:00 PM EST
658.88
+5.77 (0.88%)
After-hours: Nov 6, 2026, 7:49 PM EST
Medpace Holdings Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 2,838 | 2,530 | 2,109 | 1,886 | 1,460 | 1,142 |
Revenue Growth | 20.35% | 19.97% | 11.84% | 29.17% | 27.80% | 23.38% |
Gross Profit Gross Profit Growth | 2,051 | 1,798 | 1,427 | 1,248 | 925.11 | 701.29 |
Operating Income Operating Income Growth | 607.14 | 534.94 | 446.87 | 336.83 | 278.7 | 198.62 |
Net Income Net Income Growth | 517.83 | 451.12 | 404.34 | 282.62 | 245.21 | 181.39 |
Earnings Per Share EPS Growth | 18.03 | 15.28 | 12.63 | 8.88 | 7.28 | 4.81 |
EPS Growth | 25.93% | 20.98% | 42.23% | 21.98% | 51.35% | 25.26% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Metabolic Metabolic Growth | 915.68 | 744.96 | 457.54 | 376.84 | 244.68 | 159.9 |
Oncology Oncology Growth | 836.45 | 747.59 | 651.24 | 587.1 | 467.8 | 362.85 |
Other Sources Other Sources Growth | 379.8 | 408.55 | 431.38 | 404.84 | 296.91 | 267.42 |
Central Nervous System Central Nervous System Growth | 319.9 | 254.84 | 181.98 | 160.06 | 157.94 | 121.55 |
Cardiology Cardiology Growth | 240.69 | 239.37 | 230.45 | 193.69 | 174.63 | 119.69 |
AVAI AVAI Growth | 145.86 | 134.94 | 156.46 | 163.31 | 118.03 | 110.98 |
Revenue (Total) Revenue (Total) Growth | 2,838 | 2,530 | 2,109 | 1,886 | 1,460 | 1,142 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 705.32 | 497.05 | 669.44 | 245.45 | 28.27 | 461.3 |
Total Debt Total Debt Growth | 171.46 | 136.85 | 149.52 | 164.49 | 208.14 | 147.24 |
Net Cash (Debt) Net Cash Growth | 533.86 | 360.2 | 519.91 | 80.96 | -179.87 | 314.06 |
Net Cash Growth | 277.61% | -30.72% | 542.17% | - | - | 114.04% |
Net Cash Per Share Net Cash Per Share Growth | 18.59 | 12.20 | 16.24 | 2.54 | -5.34 | 8.33 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 723.05 | 713.22 | 608.82 | 433.37 | 388.05 | 263.33 |
Capital Expenditures CapEx Growth | -55.42 | -31.36 | -36.55 | -36.65 | -36.88 | -28.27 |
Free Cash Flow Free Cash Flow Growth | 667.63 | 681.87 | 572.27 | 396.73 | 351.17 | 235.06 |
Free Cash Flow Growth | -1.35% | 19.15% | 44.25% | 12.97% | 49.40% | 3.40% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 72.24% | 71.06% | 67.66% | 66.16% | 63.36% | 61.39% |
Operating Margin | 21.39% | 21.14% | 21.19% | 17.86% | 19.09% | 17.39% |
Pretax Margin | 22.09% | 21.44% | 22.57% | 17.80% | 19.37% | 17.67% |
Profit Margin | 18.24% | 17.83% | 19.17% | 14.99% | 16.79% | 15.88% |
FCF Margin | 23.52% | 26.95% | 27.13% | 21.04% | 24.05% | 20.58% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 36.22 | 35.07 | 25.54 | 33.28 | 26.94 | 43.12 |
Forward PE | 33.99 | 33.86 | 27.33 | 31.74 | 27.33 | 42.23 |
P/FCF Ratio | 27.36 | 23.20 | 18.04 | 23.71 | 18.81 | 33.28 |
PS Ratio | 6.44 | 6.25 | 4.90 | 4.99 | 4.53 | 6.85 |